1. Treat underlying cause(s)
2. Renoprotection
Goals of treatment
BP <>
Proteinuria <>
Treatment
Patients with chronic renal failure and proteinuria > 1 g/24 hours:
ACE inhibitor increasing to maximum dose
Add angiotensin receptor antagonist if goals are not achieved
Add diuretic to prevent hyperkalaemia and help to control BP
Add calcium-channel blocker (verapamil or diltiazem) if goals not achieved
Additional measures
Statins to lower cholesterol to <>
Stop smoking (threefold higher rate of deterioration in CRF)
Treat diabetes (HbA1c <>
Normal protein diet (0.8-1 g/kg bodyweight)
3. Correction of complications
Hyperkalaemia
Dietary restriction of potassium intake
Stop drugs causing potassium retention
Ion-exchange resins to remove potassium in gastrointestinal tract (e.g. Sodium polystyrene sulfonate)
Acidosis
Sodium bicarbonate supplements
Hypocalcaemia
Calcium carbonate supplements
Calcitrol or Vitamin D analogue (e.g. alfacalcidol)
Hyperphosphataemia
Oral calcium carbonate / acetate reduces absorption of dietary phosphate
Sevelamar used as gut phosphate binder
Nicotinamide to block intestinal sodium/phosphate cotransporter
Anaemia
Synthetic human erythropoietin
Male erectile dysfunction
Oral phosphodiesterase inhibitor (e.g. sildenafil, tadalafil, vardenafil)
4. Renal replacement therapy
Haemodialysis
Blood from patient pumped through array of semi-permeable membranes
Blood comes in close association with dialysate and substances are filtered down their concentration gradients
Approximately 4-5 hours’ treatment 3 times a week
All patients anticoagulated (e.g. heparin)
Haemofiltration
Removal of plasma water and dissolved constituents across semi-permeable membrane
Replacement with solution of desired biochemical composition
22L exchange 3 times a week
Peritoneal dialysis
Utilizes the peritoneal membrane as a semi-permeable membrane
Tube placed into peritoneal cavity and dialysate run into cavity
Dissolved substances pass into dialysate down concentration gradients
Fluid changed regularly to repeat process
Transplantation
Surgical anastomosis of human kidney on to iliac vessels of recipient
Donor ureter placed into recipient’s bladder
Immunosuppressive treatment needed (e.g. corticosterioids, azathioprine, ciclosporin)
Sources: Kumar and Clark, Clinical Medicine
No comments:
Post a Comment